Signals Blog

Researchers in Montréal announced this week that they have successfully used stem cells as a key part of a treatment for a patient with heart muscle failure due to severe heart disease. The procedure involves implanting autologous stem cells into the heart muscle of a patient during a coronary bypass procedure. The stem cells stimulate greater healing and regeneration of the heart muscle tissue, which assists in the heart’s ability to contract and pump more blood through the body.

The goal is to provide an alternative therapy for the treatment of severe heart failure that is less invasive and less expensive than heart replacement, currently the only treatment option for these patients. The researchers involved in the study include Nicolas Noiseux and Samer Mansour from the University of Montréal Hospital Centre and Denis-Claude Roy, Maisonneuve-Rosemont Hospital.

The study will recruit an additional 20 patients in Montréal in the first phase of the trial, with a second centre to be added in Toronto.

Read more on the University of Montréal news page and via the Canadian Press.

See related blog posts: Overcoming barriers to successful heart transplants, Cell development to reduce the impacts of heart failure and Muscle repair enhanced by stem cells.

The following two tabs change content below.

Stem Cell Network